LITTLE KNOWN FACTS ABOUT MBL77.

mutations offered the fact that, as explained down below, CLL therapy relies around the existence or absence of such mutations. The existing consensus is always that, apart from clonal mutations, subclonal mutations using a variant allelic frequency ranging from five to 10% (and thus down below the threshold of detection by conventional molecular m